Article
Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia.
Genes - 6 Jul 2020
Higgins Alexandra, Shah Mithun Vinod
Abstract excerpt
A subset of acute myeloid leukemia (AML) arises either from an antecedent myeloid malignancy (secondary AML, sAML) or as a complication of DNA-damaging therapy for other cancers (therapy-related myeloid neoplasm, t-MN). These secondary leukemias have unique biological and clinical features that distinguish them from de novo AML. Over the last decade, molecular techniques have unraveled the complex subclonal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
